This study examined whether an increased activity of the endothelium-derived relaxing factor, nitric oxide, may account for the hyporesponsiveness to vasoconstrictors in portal hypertension. W e performed dose-response curves to methoxamine, an eadrenoceptor agonist, with and without N"dtr0-Larginin
Renal response to methoxamine in portal hypertensive rats: role of prostaglandins and nitric oxide
✍ Scribed by Joaquín García-Estañ; Noemí M. Atucha; Roberto J. Groszmann
- Book ID
- 118567304
- Publisher
- Elsevier Science
- Year
- 1996
- Tongue
- English
- Weight
- 669 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Systemic and especially splanchnic arterial vasodilation accompany chronic portal hypertension. Different soluble mediators causing this vasodilation have been proposed, the strongest evidence being for nitric oxide (NO). No data exist if structural vascular changes may partly account for this vasod
This study investigated the effect of vasopressin on portal-systemic collaterals in portal hypertensive rats and the influence of nitric oxide (NO) and prostaglandin on the responsiveness of collateral vessels to vasopressin. The vascular responsiveness to graded concentrations of vasopressin was te
This study investigates the effects of inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME), the inhibition of prostaglandin synthesis with indomethacin and the combined effects on gastric mucosal hyperemia of ketamine-anesthetized rats with portal hypertension induced b
receptors to adenylyl cyclase and K / channel opening. 24 The ton, DC. activation of inhibitory guanine nucleotide regulatory pro-